<unk>  (INN; NKTR-118), or PEGylated naloxol, trade name Movantik, is a peripherally-selective opioid antagonist under development by AstraZeneca, licensed from Nektar, for the treatment of opioid-induced constipation.
Naloxegol
Carbasalate calcium
Tolnaftate
Perflubron
Metolcarb
Mersalyl acid
Itramin tosilate
Metiltriazotion